EV/EBITDA:
-11.89+0.06(+0.50%)Summary
- As of today, VKTX EV/EBITDA is -11.89, with a rise of +0.06 (+0.50%) during the most recent trading session on December 31, 2025.
- Over the past year, VKTX EV/EBITDA has increased by +11.94 (+50.10%).
- VKTX EV/EBITDA is now -3497.14% below its all-time high of 0.35.
Performance
VKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VKTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.5% | -0.5% | -0.4% |
| 1M1 Month | +5.3% | -5.3% | -4.4% |
| 3M3 Months | -45.5% | +45.6% | +33.9% |
| 6M6 Months | -16.3% | +50.4% | +32.8% |
| YTDYTD | +50.1% | -9.1% | -12.6% |
| 1Y1 Year | +50.1% | -9.1% | -12.6% |
| 5Y5 Years | -199.5% | +1887.3% | +524.9% |
VKTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -11.36 | -4.7% | -13.29 | +10.5% |
| 3M | 3-Month | -8.17 | -45.5% | -14.20 | +16.3% |
| 6M | 6-Month | -8.17 | -45.5% | -18.48 | +35.7% |
| 1Y | 1-Year | -8.10 | -46.8% | -25.79 | +53.9% |
| 3Y | 3-Year | -6.00 | -98.2% | -95.77 | +87.6% |
| 5Y | 5-Year | 0.35 | -3497.1% | -95.77 | +87.6% |
| All-Time | All-Time | 0.35 | -3497.1% | -95.77 | +87.6% |
VKTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.89(+50.1%) |
| 2024 | -23.83(-59.5%) |
| 2023 | -14.94(-80.0%) |
| 2022 | -8.30(-191.2%) |
| Date | Value |
|---|---|
| 2021 | -2.85(+28.2%) |
| 2020 | -3.97(+65.2%) |
| 2018 | -11.42(-893.0%) |
| 2016 | -1.15 |
FAQ
- What is Viking Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
- What is VKTX EV/EBITDA year-to-date change?
- What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Viking Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of VKTX is -11.89
What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high EV/EBITDA is 0.35
What is VKTX EV/EBITDA year-to-date change?
Viking Therapeutics, Inc. EV/EBITDA has changed by +11.94 (+50.10%) since the beginning of the year
What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, VKTX EV/EBITDA has changed by +11.94 (+50.10%)